首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Frontiers in oncology

缩写:FRONT ONCOL

ISSN:2234-943X

e-ISSN:2234-943X

IF/分区:3.3/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引33690
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yanju Li,Xiaomeng Yang,Yingjin Zhang et al. Yanju Li et al.
Purpose: To evaluate and compare the predictive performance of machine learning methods using clinical-semantic, radiomic, and combined features in distinguishing squamous cell carcinoma (SCC) from adenocarcinoma (ADC) in...
Jianting Man,Xingru Tao,Zongyuan Zhang et al. Jianting Man et al.
Background: Although apolipoprotein 1 (APOL1) expression is upregulated in several types of cancers, including thyroid cancer (THCA), its specific role in THCA remains unclear. The aim of the present study was to analyze ...
Karim El-Marouk,Esra Degerli,Lukas Käsmann et al. Karim El-Marouk et al.
Background: Stereotactic body radiation therapy (SBRT) is the established standard of care for medically inoperable early-stage non-small cell lung cancer (ES-NSCLC). When a biopsy is unfeasible, it is often delivered emp...
Hasan Alanya,Sreekar Kasturi,Kanat Yalcin et al. Hasan Alanya et al.
Skull-base plasmacytoma (SBP) is a rare plasma cell neoplasm that typically presents as a slow-growing skull-base lesion in older adults; however, its molecular underpinnings are poorly characterized, limiting targeted therapeutic intervent...
Renba Liang,Ling Lei,Xinxiao Li et al. Renba Liang et al.
Objective: To explore the efficacy and safety of toripalimab combined with gemcitabine and cisplatin (GP) induction chemotherapy and sequential concurrent chemoradiotherapy in LANPC treatment. ...
Yongqiang Wang,Alex Zwanenburg,Jiang Zhang et al. Yongqiang Wang et al.
Purpose: To guide the preselection of highly repeatable radiomic features (RFs) in downstream analysis without further analysis its repeatability, a detailed radiomic feature robustness databank (RF-RobustDB) was establis...
C A Iannuzzi,F Pagano,M Tomeo et al. C A Iannuzzi et al.
Introduction: Oncolytic viruses (OVs) are promising therapeutic agents in oncology that directly lyse tumor cells, modulate the immune response, and alter the tumor microenvironment. Non-human OVs offer advantages over th...
Lu Wang,Huiting Zhang,Xifeng Jing et al. Lu Wang et al.
Introduction: Mutations in isocitrate dehydrogenase 1 (mIDH1) generate the oncometabolite (R)-2-hydroxyglutarate (R-2HG), which promotes tumorigenesis by inhibiting α-ketoglutarate-dependent enzymes and altering the epig...
Xiaodong Luo,Shuo Gao,Kaiyang Sun et al. Xiaodong Luo et al.
Poly (ADP ribose) polymerase 1 (PARP1) plays a central role in the response of DNA damage induced by tumor radiotherapy. This paper systematically reviewed the structural and functional characteristics of PARP1 and its molecular mechanism i...